Cargando...
Challenges for Drug Repurposing in the COVID-19 Pandemic Era
The coronavirus disease (COVID-19) pandemic has affected an estimated 16 million persons and caused 0.6 million deaths worldwide by September 2020. The pandemic has led to a rush to repurpose existing drugs, although the underlying evidence base is of variable quality. The improving knowledge of the...
Guardado en:
| Publicado en: | Front Pharmacol |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7677570/ https://ncbi.nlm.nih.gov/pubmed/33240091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.588654 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|